Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
Australian Clinical Labs Limited (ASX:ACL), a leading provider of healthcare facilities and pathology services, has attracted favorable analyst ratings from E&P and Ord Minnett following the release of its financial results for the year ended 30 June 2025 (FY25).
Neuren Pharmaceuticals Limited (ASX:NEU) has announced its half-year financial results for the six months ended 30 June 2025 (H1 2025), reporting profit after tax ofAUD 15.0 million, up fromAUD 8.0 millionin the prior corresponding period. The increase was primarily driven by continued growth in …
Polynovo Limited (ASX:PNV), an Australian-based medical device company specialising in its patented NovoSorb® technology, has attracted favourable analyst attention following its FY25 results. Both Bell Potter Securities and Macquarie Research have reaffirmed positive views on the company.
Ansell Limited (ASX:ANN), a global provider of personal protection and safety solutions, has released its financial results for the year ended 30 June 2025 (FY25), reporting revenue growth across both its Industrial and Healthcare segments.
Telix Pharmaceuticals Ltd (ASX:TLX) has received renewed confidence from two major equity research houses, withBell Potter Securities (Institutional)andTD Cowenboth issuingBuyratings on the stock.
Cochlear Limited (ASX:COH) has released its financial results for the year ended 30 June 2025, marking a year of growth in implant sales and the launch of a major new product. In FY25, over 53,000 people received one or two of the company’s cochlear …
The Hydration Pharmaceuticals Company Limited (ASX:HPC), trading as Hydralyte USA, has announced the launch of its new Hydralyte Plus Metabolic Support product, with initial sales achieved through e-commerce platforms and Amazon USA. The update saw the company’s share price rise 30% to 1.3 cents …
Audeara Limited (ASX:AUA) saw its share price surge31.6% to 2.5 centson Tuesday morning (12 August) after securing a landmarkLicensing Agreement with Eastech (Huizhou) Co., Ltd., a wholly owned subsidiary of Taiwan-listedEastech Holding Limited (TWSE: 5225).
Global Health Limited (ASX:GLH)has entered into a contract with Jarrah House, a New South Wales-based alcohol and other drug (AOD) rehabilitation service, for the implementation of its cloud-based MasterCare+ Client Management System (CMS) and associated digital tools. The agreement is valued at AUD 186,748.10 …
Shares inAvita Medical Inc (ASX:AVH)came under significant selling pressure on Friday following the release of its second-quarter results for the three months ended 30 June 2025. The regenerative medicine company’s stock opened sharply lower, dropping as much as 22.9% to an intraday low of …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…